首页 >
法规速递
-
关于公开征求《化学仿制药参比制剂目录（第九十八批）》（征求意见稿）意见的通知-2025/9/17
2025-09-18查看详情 > -
Document: Minutes - Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) (24 September 2025)-2025/10/22
2025-10-23查看详情 > -
Document: Step-by-step guide: How to evaluate a CT application - CTIS Training Programme - Module 06-2025/11/25
2025-11-26查看详情 > -
国家药监局关于进一步明确《Q12:药品生命周期管理的技术和监管考虑》国际人用药品注册技术协调会指导原则有关适用问题的公告（2025年第119号）-2025/12/17
2025-12-18查看详情 > -
Page: Human Medicines-2026/2/2
2026-02-03查看详情 > -
Document: European Medicines Agency’s data protection notice for the EudraVigilance Signal and Safety Analytics (EV SSA) platform-2026/3/10
2026-03-11查看详情 > -
Page: Animal health practitioners-2026/4/8
2026-04-09查看详情 > -
国家药监局关于修订氢化泼尼松注射液、盐酸哌替啶注射液说明书的公告（2022年第122号）-2022/12/29
2022-12-30查看详情 > -
国家药监局关于49批次药品不符合规定的通告（2023年第30号）-2023/7/17
2023-07-21查看详情 > -
Draft Guidance: Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products-2024/1/29
2024-02-05查看详情 >
